The U.S. Food and Drug Administration has delayed reviews of several drugs selected for the Trump administrations new ...
The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...
ARPA-H said it is accepting proposals for the program across three technical areas: developing a patient-facing AI agent, developing a supervisory agent to ensure continued accuracy and safety of ...
Natividad has earned national recognition from the American College of Surgeons (ACS) National Surgical Quality Improvement ...
JOINT BASE SAN ANTONIO-FORT SAM HOUSTON, Texas – Brooke Army Medical Center received an “A” Leapfrog Hospital Safety Grade ...
The next Medical Device User Fee Amendments, which will set how much the FDA can raise from the industry in fees over a ...
A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...
LifespanningRx Earns LegitScript Certification for Compliant Longevity & Telehealth Medical Services
LifespanningRx Achieves LegitScript Certification, Marking a Major Milestone in Compliant Longevity Medicine Longevity ...
In this conversation, Tina Eden, R.N., CEO of Virginia Gay Hospital, and Jacinda Bunch, Ph.D., R.N., assistant professor at ...
Insilico Medicine (3696.HK), a clinical-stage, generative AI-driven drug discovery company, today announced the completion of ...
Study: FDA regulation of abortion drug mifepristone from 2011 to 2023 shaped by evidence and caution
An analysis of internal Food and Drug Administration documents by researchers at the Johns Hopkins Bloomberg School of Public Health finds that the agency generally followed cautious and ...
New data science-driven alert framework expected to reduce clinician burden by 45% while preserving industry-leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results